Hydroxyurea in the treatment of major -thalassemia and importance of genetic screening

By Alebouyeh M.  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 430-433

Springer Publishing Company

Access to resources Recommend Favorite

Descriptive profile of β-thalassemia mutations in West Bengal population: a hospital-based study

By Bhattacharyya Deboshree   Mukhopadhyay Ashis   Basak Jayasri  

International Journal of Hematology, Vol. 99, Iss. 3, 2014-03 ,pp. : 345-353

Springer Publishing Company

Access to resources Recommend Favorite

Tricuspid regurgitation in patients with -thalassemia major

By Wu K.  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 779-783

Springer Publishing Company

Access to resources Recommend Favorite

Targeted Correction of the Point Mutations of β-Thalassemia and Targeted Mutagenesis of the Nucleotide Associated with HPFH by RNA/DNA Oligonucleotides: Potential for β-Thalassemia Gene Therapy

By Li Z-H.   Liu D-P.   Yin W-X.   Guo Z-C.   Liang C-C.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 2, 2001-02 ,pp. : 530-538

Academic Press

Access to resources Recommend Favorite

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with -thalassemia major

By Wu K.  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 471-473

Springer Publishing Company

Access to resources Recommend Favorite